Atlas Trials

Investigation of the Contents and Prognostic Values of Glucose Metabolism Molecules in Patients With Lung Adenocarcinoma

Clinical trial NCT03641105 · UNKNOWN

Trial details

NCT number
NCT03641105
Sponsor
Shanghai Zhongshan Hospital
Status
UNKNOWN
Study type
OBSERVATIONAL
Lung CancerGlycolysisDiagnosisSurvival
Start date
2014-01-01
Primary completion
2019-03-01
Enrollment
100

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.